Safety, tolerability, pharmacokinetics, and antimalarial activity of MMV533: a phase 1a first-in-human, randomised, ascending dose and food effect study, and a phase 1b Plasmodium falciparum volunteer infection study
Titel:
Safety, tolerability, pharmacokinetics, and antimalarial activity of MMV533: a phase 1a first-in-human, randomised, ascending dose and food effect study, and a phase 1b Plasmodium falciparum volunteer infection study
Auteur:
Bestgen, Benoit Jones, Sam Thathy, Vandana Kuemmerle, Andrea Barcelo, Catalina Haouala, Amina Gossen, Denis Marx, Michael W Di Resta, Ilaria Szramowska, Maja Webster, Rebecca A Llewellyn, Stacey Ritacco, Dominic A Yeo, Tomas Leroy, Didier Barber, Bridget E Fidock, David A Griffin, Paul Lickliter, Jason Chalon, Stephan
Verschenen in:
The lancet infectious diseases
Paginering:
Jaargang 25 () nr. 5 pagina's 507-518
Jaar:
2025
Inhoud:
Uitgever:
The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license